TRCT
NXL icon

Tower Research Capital (TRC)’s Nexalin Technology NXL Stock Holding History

Tower Research Capital (TRC)’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697 Hold
70
– – ﹤0.01% 4969
2026
Q1 		$736 Sell
70
-8
-10% -$125 ﹤0.01% 4793
2025
Q4 		$1.3K Buy
78
+30
+63% +$1.01K ﹤0.01% 4719
2025
Q3 		$1.31K Sell
48
-203
-81% -$5.75K ﹤0.01% 4824
2025
Q2 		$7.43K Buy
251
+197
+365% +$8.3K ﹤0.01% 4056
2025
Q1 		$3.18K Buy
+54
New +$4.43K ﹤0.01% 4455
2024
Q4 		– Sell
-219
Closed -$4.4K – 5908
2024
Q3 		$4.4K Sell
219
-110
-33% -$3.4K ﹤0.01% 4559
2024
Q2 		$16.7K Buy
329
+26
+9% +$1.15K ﹤0.01% 3858
2024
Q1 		$12.7K Buy
303
+1
+0.3% +$12 ﹤0.01% 3456
2023
Q4 		$3.67K Hold
302
– – ﹤0.01% 5052
2023
Q3 		$3.99K Hold
302
– – ﹤0.01% 4934
2023
Q2 		$8.1K Hold
302
– – ﹤0.01% 4474
2023
Q1 		$7K Buy
302
+27
+10% +$803 ﹤0.01% 4759
2022
Q4 		$6K Buy
+275
New +$12.6K ﹤0.01% 4743

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Tower Research Capital (TRC)'s NXL Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Nexalin Technology (NXL) position steady in Q2 2026 at 70 shares worth $697. The position accounts for ﹤0.01% of the portfolio, ranked #4969.

Tower Research Capital (TRC) first reported a position in NXL in Q4 2022 and has held it in 14 quarters since. The position peaked at $16.7K in Q2 2024. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Tower Research Capital (TRC) held 70 shares of Nexalin Technology worth $697 as of Q2 2026.
  • Tower Research Capital (TRC) left its Nexalin Technology share count unchanged in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4969 holding.
  • Tower Research Capital (TRC) first reported a position in Nexalin Technology in Q4 2022 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Nexalin Technology position peaked at $16.7K in Q2 2024.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.